Company Directory / Biotechnology Research
PrivateFor profitBiotechnology ResearchVancouver, BC, Canada
Aspect Biosystems
Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.
- Founded
- 2013 13 years ago
- Staff
- 51-100 116 on LinkedIn
- Followers
- 23k on LinkedIn
- Funding
- $81M as listed, USD
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body. Aspect is creating these next-generation cell therapies by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, computational design tools, therapeutic cells, and… Read all
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body. Aspect is creating these next-generation cell therapies by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, computational design tools, therapeutic cells, and advanced biomaterials. Aspect is advancing a pipeline of bioprinted tissue therapeutics across multiple disease areas in the endocrine and metabolic space including diabetes, obesity, rare endocrine disorders, and liver disease. Aspect's pipeline development strategy involves both proprietary programs as well as strategic partnerships, including a collaboration with Novo Nordisk focused on diabetes and obesity.
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed. 116 people list it on LinkedIn.
Age
13 years old.
Reach
Website ranked #4,157,563 in the world for traffic, about 2k visits a month. 22,985 followers on LinkedIn.
What it does
BiotechnologyLife Sciencebioprintingtissue engineeringregenerative medicinetherapeutic development
Funding, as listed
$81M raised in total
- Rounds14
- LatestGrant, Jul 2024
- Latest amountUSD 115,000,000
- Investors23, 9 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Aspect Biosystems, field by field. Contact details are held but never shown.
The company
- Name
- Aspect Biosystems
- Type
- For profit
- Status
- Private
- Founded
- 2013
- Founders
- Konrad Walus, Sam Wadsworth, Simon Beyer, Tamer Mohamed
- Industry
- Biotechnology Research
- Categories
- Biotechnology, Life Science
- Specialities
- bioprinting, tissue engineering, regenerative medicine, therapeutic development
Where
- City
- Vancouver
- Region
- BC
- Country
- Canada
Size and reach
- Staff band
- 51-100
- People on LinkedIn
- 116
- LinkedIn followers
- 22,985
- Web traffic rank
- #4,157,563
- Monthly web visits
- 2,461
Funding, as listed
- Total
- $81,067,874 USD
- Rounds
- 14
- Latest round
- Grant
- Latest round date
- Jul 2024
- Latest amount
- 115,000,000 USD
- Investors
- 23
- Lead investors
- 9
- Listing status
- private
About this record
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Growth, as the source summarises it
Aspect Biosystems secured a $72.75 million government investment to advance bioprinted tissue therapeutics. Additionally, the company announced a $200 million partnership with the Governments of Canada and British Columbia to further develop bioprinted tissue therapeutics.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Biotechnology Research in Canada.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 136,547 companies in Canada and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.